Skip to content

Medical-device intelligence

NWG: Autoantibodies, Glutamic Acid Decarboxylase (Gad)

FDA product code NWG: Autoantibodies, Glutamic Acid Decarboxylase (Gad). View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NWG
FDA device name
Autoantibodies, Glutamic Acid Decarboxylase (Gad)
Device class
2
Regulation number
866.5660
Medical specialty
Immunology
Review panel
IM

FDA definition

The device is used for the semi-quantitative determination of glutamic acid decarboxylase (GAD) autoantibodies in human serum as an aid in the diagnosis of Type I diabetes mellitus (autoimmune mediated diabetes).
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Nov 4, 2005 to Nov 7, 2007.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NWG · Autoantibodies, Glutamic Acid Decarboxylase (Gad)20

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

2 matching records
Device / recordCompany in FDA recordSourceSource date
KRONUS GAD AUTOANTIBODY ELISA ASSAY KITK072135 · NWGKronus Market Development Associates, Inc.510(k)Nov 7, 2007FDA decision date
KRONUS GLUTAMIC ACID DECARBOXYLASE ANTIBODY KITK051061 · NWGKronus Market Development Associates, Inc.510(k)Nov 4, 2005FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗